EMEA-003519-PIP01-23 - paediatric investigation plan
zenocutuzumab
PIPHuman
Key facts
- Active Substance
- zenocutuzumab
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Decision number
- P/0061/2024
- PIP number
- EMEA-003519-PIP01-23
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of lung cancer
- Treatment of pancreatic cancer
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Merus N.V.
E-mail: enquiries@merus.nl
Tel: +31 850162500- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date